Arcus Biosciences (RCUS) Research & Development (2017 - 2025)
Historic Research & Development for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to $141.0 million.
- Arcus Biosciences' Research & Development rose 1463.41% to $141.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $503.0 million, marking a year-over-year increase of 1431.82%. This contributed to the annual value of $448.0 million for FY2024, which is 3176.47% up from last year.
- According to the latest figures from Q3 2025, Arcus Biosciences' Research & Development is $141.0 million, which was up 1463.41% from $139.0 million recorded in Q2 2025.
- In the past 5 years, Arcus Biosciences' Research & Development registered a high of $141.0 million during Q3 2025, and its lowest value of $50.6 million during Q4 2021.
- In the last 5 years, Arcus Biosciences' Research & Development had a median value of $82.0 million in 2023 and averaged $91.3 million.
- As far as peak fluctuations go, Arcus Biosciences' Research & Development soared by 18686.8% in 2021, and later crashed by 811.45% in 2022.
- Over the past 5 years, Arcus Biosciences' Research & Development (Quarter) stood at $50.6 million in 2021, then soared by 58.14% to $80.0 million in 2022, then grew by 16.25% to $93.0 million in 2023, then increased by 8.6% to $101.0 million in 2024, then surged by 39.6% to $141.0 million in 2025.
- Its last three reported values are $141.0 million in Q3 2025, $139.0 million for Q2 2025, and $122.0 million during Q1 2025.